![]() |
|
|
Molecular Pharmacology, Vol 12, 440-453, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Medical Viral Oncology, Roswell Park Memorial Institute, Buffalo, New York 14263
2 Beecham Pharmaceutical Research Division,
Brockham Park, Betchworth, Surrey, England
3 Division of Biophysics, School of Hygiene and Public Health,
The Johns Hopkins University, Baltimore,
Maryland 21205
Extensive investigations were made of the chronic biological properties of the polyinosinic·polycytidylic acid (rIn·rCn) duplex, along with two duplexes having mismatched
base pairs, rIn·r(C12, U)n and rIn·r(C29,G)n, and a double-stranded RNA (BRL 5907)
obtained from virus-like particles in Penicillium cultures. Earlier we had shown that
mismatched polynucleotide duplexes are comparable in their antiviral properties to
rIn·rCn, but possess much less pronounced immediate secondary effects than the rIn·rCn
molecule. In this work the relative antiviral activities against encephalomyocarditis
virus infection in mice of these four duplexes were compared and rIn·r(C29,G)n was found
to be somewhat less active than the other double-stranded RNAs. In experiments on
mice with a 7-day repeat dose, rIn·rCn, and BRL 5907 caused a spectrum of toxic effects: a
substantial loss of body weight, acute lymphopenia, and thrombocytopenia; on day 8,
neutrophil leukocytosis, anemia, splenomegaly, and thymic atrophy were also noted. In
contrast, rIn·r(C29,G)n was less toxic and did not promote thymic atrophy; rIn·r(C12,U)n
effected even fewer secondary biological events since it did not promote anemia or a
change in body weight, modify the neutrophil count, or induce the thymic atrophy,
effects characteristic of rIn·rCn and BRL 5907. All inducers, including the mismatched
duplexes, induced some degree of thrombocytopenia, acute lymphopenia, and splenomegaly by day 8. Splenomegaly may be due to the mitogenic potential of double-stranded RNA on splenocytes, a reaction known not to be completely abrogated by
purposeful mismatching of bases in RNA. Thus these studies established an order of
capacity for triggering specific secondary toxic responses: BRL 5907
rIn·rCn >
rIn·r(C29,G)n [unknown] rIn·r(C12,U)n. Using radioactive rIn·rCn as a probe, serum antibody
was assayed in both mice and rabbits following repeated administration of the three
synthetic double-stranded RNAs: rIn·rCn; appeared the most immunogenic of the three.
The order of immunogenic potential for mismatched duplexes, tested only by cross-reaction, was BRL 5907 > rIn·rCn > rIn·r(C29,G)n [unknown] rIn·r(C12,U)n. Interestingly, antibody
raised against the naturally occurring RNA could interact effectively with antibody
raised specifically against rIn·rCn, thereby supporting the notion that extensive cross-reactivity is shared by antibodies raised against the double-stranded RNAs with the
various sequences. Companion studies in vitro, which evaluated the relative rates of
polymer degradation with pancreatic RNase, confirmed that mismatching of the base
pairs in the duplex RNA, as exemplified by rIn·r(C12,U)n and rIn·r(C29,G)n, would enhance the rate of polymer degradation. The natural double-stranded RNA (BRL 5907)
was degraded much more slowly than the others. Thus this mechanism appears to be
one of the factors in the differential effects observed in vivo. Together with our earlier
work, the current results more firmly establish the importance of the "kinetic term" in
modifying the therapeutic ratios of double-stranded RNAs in intact biological systems
and illustrate how the spectrum of biological responses to double-stranded RNAs can
be modulated by this strategy.
This article has been cited by other articles:
![]() |
B. B. Gowen, M.-H. Wong, K.-H. Jung, A. B. Sanders, W. M. Mitchell, L. Alexopoulou, R. A. Flavell, and R. W. Sidwell TLR3 Is Essential for the Induction of Protective Immunity against Punta Toro Virus Infection by the Double-Stranded RNA (dsRNA), Poly(I:C12U), but not Poly(I:C): Differential Recognition of Synthetic dsRNA Molecules J. Immunol., April 15, 2007; 178(8): 5200 - 5208. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Seymour Review : Synthetic Polymers with Intrinsic Anticancer Activity Journal of Bioactive and Compatible Polymers, January 1, 1991; 6(2): 178 - 216. [PDF] |
||||